Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Drake

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Journal of the American Podiatric Medical Association|December 16, 1997
Impact of onychomycosis on quality of lifeL A Drake
Emergency Medicine Clinics of North America|November 1, 1985
Dermatologic formularyL A Drake
Archives of Dermatology|December 1, 1995
The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study GroupL A Drake, L E Millikan
Dermatologic Clinics|October 1, 1992
Ocular and periocular infectionsM Holzberg, R D Stulting, L A Drake
Journal of the American Academy of Dermatology|October 1, 1994
Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study GroupL A Drake, J D Fallon, A Sober
Archives of Dermatology|September 1, 1996
The future of Medicare. Their plans, your practice, Medicare reform, and how it will affect the practice of dermatologyL A Drake, K P Yale, R Gillies
International Journal of Dermatology|March 1, 1997
Dermatology and the recently returned traveler: infectious diseases with dermatologic manifestationsL C Lucchina, M E Wilson, L A Drake
International Journal of Dermatology|October 9, 1999
Quality of life for patients with onychomycosisL E Millikan, D W Powell, L A Drake
The British Journal of Dermatology|May 24, 2018
Alopecia areata: a review of disease pathogenesisF Rajabi, L A Drake, M M Senna, et al.
Journal of the American Academy of Dermatology|November 12, 1998
Recommendations for credentialing and privileging. Guidelines/Outcomes CommitteeL A Drake, R W Goltz, C S Livingood, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Journal of the American Podiatric Medical Association|December 16, 1997
Impact of onychomycosis on quality of lifeL A Drake
Emergency Medicine Clinics of North America|November 1, 1985
Dermatologic formularyL A Drake
Archives of Dermatology|December 1, 1995
The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study GroupL A Drake, L E Millikan
Dermatologic Clinics|October 1, 1992
Ocular and periocular infectionsM Holzberg, R D Stulting, L A Drake
Journal of the American Academy of Dermatology|October 1, 1994
Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study GroupL A Drake, J D Fallon, A Sober
Archives of Dermatology|September 1, 1996
The future of Medicare. Their plans, your practice, Medicare reform, and how it will affect the practice of dermatologyL A Drake, K P Yale, R Gillies
International Journal of Dermatology|March 1, 1997
Dermatology and the recently returned traveler: infectious diseases with dermatologic manifestationsL C Lucchina, M E Wilson, L A Drake
International Journal of Dermatology|October 9, 1999
Quality of life for patients with onychomycosisL E Millikan, D W Powell, L A Drake
The British Journal of Dermatology|May 24, 2018
Alopecia areata: a review of disease pathogenesisF Rajabi, L A Drake, M M Senna, et al.
Journal of the American Academy of Dermatology|November 12, 1998
Recommendations for credentialing and privileging. Guidelines/Outcomes CommitteeL A Drake, R W Goltz, C S Livingood, et al.
Pageof 6